Galantamine, another AChE inhibitor, decreases inflammation and has been shown to be effective in animal models of endotoxemia, inflammatory bowel disease, lupus (41–43), and metabolic syndrome in humans (44). The gene discussed is ACHE; the disease is serum lipopolysaccharide activity.